Pfizer Reports Young Boy Dies From Cardiac Arrest After Participating in Gene Therapy Study

Pharmaceutical giant Pfizer has reported a young boy has died due to cardiac arrest after receiving the company’s experimental gene therapy for Duchenne muscular dystrophy.

A Pfizer spokesperson told Reuters in an exclusive email, “A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study.”

Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.

According to Johns Hopkins Medicine...